Corporates profit from pinkwashing

NewsGuard 100/100 Score

Companies that try to increase sales of their products by adopting the color pink and pink ribbons to imply that they support breast cancer research-a practice called pinkwashing-but at the same time permit the use of chemicals shown to cause cancer are committing a form of social injustice against women, according to a thought-provoking article in Environmental Justice, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com) The entire issue is available online at www.liebertpub.com/env

Amy Lubitow, Portland State University (Oregon), and Mia Davis, Campaign for Safe Cosmetics (Boston, MA), contend that aligning oneself with a cause such as breast cancer, while carrying out research, manufacturing, or other types of policies or processes that involve the use of chemicals with a proven link to cancer crosses a critical line between just and unjust practices. The authors state that "pinkwashing simultaneously increases profits and potentially contributes to increasing cancer rates and obscures an environmental health discourse that recognizes the environmental causes of breast cancer-" They support and expand on this view in the article entitled, "Pastel Injustice: The Corporate Use of Pinkwashing for Profit."

"The authors of this article draw needed attention to the dangerous use of consumers' social and sometimes environmental consciousness by institutions who contribute to environmental health disparities. The blind financial support of these entities, by affected consumers, is a form of environmental injustice that is clearly elucidated by the authors," said Sylvia Hood Washington, PhD, ND, MSE, MPH, Editor-in-Chief of Environmental Justice, and Research Associate Professor at the University of Illinois at Chicago School of Public Health.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels